- £61.35bn
- £74.71bn
- £30.33bn
- 86
- 53
- 75
- 86
REG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - FDA accepts new drug application for gepotidacin
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Positive results of ANCHOR trials of depemokimab
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Zantac (ranitidine) litigation settlements
AnnouncementREG - GSK PLC - Positive efficacy data of Arexvy over 3 seasons
AnnouncementREG - Allianz Global Invs - Top 10 holdings
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Positive EU opinion for GSK liquid Menveo vaccine
AnnouncementREG - GSK PLC - Statement: Zantac (ranitidine) litigation
AnnouncementREG - GSK PLC - Japan Filing Acceptance: Blenrep Multiple Myeloma
AnnouncementREG - GSK PLC - China Breakthrough Therapy Designation for Blenrep
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Positive mRNA flu vaccine Phase II headline data
AnnouncementREG - GSK PLC - Statement: Zantac (ranitidine) litigation
AnnouncementREG - GSK PLC - Change of Registered Office
Announcement